knowledge for growth, Europe’s finest life sciences conference

FreeMind Group is proud to support the 14th edition of Europe’s finest life sciences conference knowledge for growth.

Where: Ghent, Belgium
When: May 17, 2018

The cream of the European life sciences community will be attending this business conference, attracting decision makers from biotech, pharma and medtech as well as investors, universities, topnotch research institutes, policymakers and competence providers. We are expecting 1,300 participants from about 550 companies & organisations.

The conference features an exciting programme providing vital insight into the global life sciences landscape, B2B Partnering powered by EBD Group’s partneringONE®, a trade fair with 100+ exhibitors and a scientific poster area.

Register here

,

NDFS13 FreeMind Group Presentation: Grant Writing in the Digital Age

Ayal Ronen of the FreeMind Group gave a demonstration of a new shared work space we have developed and how it is propelling grant writing into the digital age.

View Slide Deck

,

NDFS13 NINDS Presentation: Overview and Update on HHS SBIR/STTR Programs

Dr. Charles Cywin of the National Institute of Neurological Disorders and Stroke spoke about the programs available to support neuroscience translational research.

View Slide Deck

,

NDFS13 NIH Presentation: Overview and Update on HHS SBIR/STTR Programs

Dr. Matthew Portnoy of the National Institutes of Health gave updates on the Small Business Innovation Research and Small Business Technology Transfer Programs.

View Slide Deck

,

NDFS13 Life Science Nation Presentation: The 10 Myths of Fundraising

Dennis Ford of Life Science Nation shared tips on interacting with investors as you work on a strategic method of fundraising for your R&D.

View Slide Deck

,

NDFS13 Company Presentation: Tangen Biosciences’ Successful Non-Dilutive Funding Journey

John Nobile of Tangen Biosciences talked about his company’s process in achieving their recent contract with BARDA.


,

NDFS13 BARDA Presentation: Partnering with the Biomedical Advanced Research and Development Authority

Dr. Joe Larsen of the Biomedical Advanced Research and Development Authority discussed current CBRN threats and BARDA’s role in developing and stockpiling countermeasures.

View Slide Deck

,

NDFS13 Company Presentation: Profusa’s Successful Non-Dilutive Funding Journey

Dr. Natalie Wisniewski, of Profusa, Inc., gave some insight about her company’s non-dilutive funding journey, starting with their initial grant from DARPA in 2011 through to today.


,

NDFS13 USAMRMC Presentation: Innovative Partnerships with the U.S. Army for Medical Technologies

Dr. James B. Phillips of USAMRMC, Department of Defense, shared with the audience the mission of the US Army Medical Research and Material Command and the Medical Technology Enterprise Consortium, discussing opportunities available for partnering and engaging with Industry.

View Slide Deck